Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:43:57.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T08:15:19.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about various types of lymphoma and their treatment, as well as changes in collaborators and the revision number. Notably, the principal investigator's name has been added.
    Difference
    30%
    Check dated 2025-04-16T01:32:41.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-08T19:55:10.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T13:43:25.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.6%
    Check dated 2025-02-24T14:52:06.000Z thumbnail image

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.